05/29/2024
3:43 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/29/2024
3:46 PM | Immunocore (Issuer)
KRISHANA RANJEEV (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/28/2024
3:17 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
3:15 PM | Bell John Irving (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:15 PM | Herbst Roy Steven (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:15 PM | Immunocore (Issuer)
Peterson Kristine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:15 PM | Immunocore (Issuer)
Ratcliffe Peter John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/23/2024
3:50 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:13 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:00 AM | Immunocore (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/12/2024
3:34 PM | Immunocore (Filer)
| Form ARS | |
04/05/2024
3:35 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
3:34 PM | Immunocore (Filer)
| Form 424B7 | |
04/02/2024
3:45 PM | Immunocore (Filer)
| Form PRE 14A | |
04/01/2024
11:36 AM | Immunocore (Subject)
St Leger Tina Amber (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
7:51 PM | Immunocore (Filer)
| Form S-3ASR | |
03/20/2024
7:55 PM | Immunocore (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/11/2024
7:19 AM | FMR LLC (Filed by)
Immunocore (Subject)
| Form SC 13G | |
03/07/2024
8:45 PM | GENERAL ATLANTIC, L.P. (Filed by)
Immunocore (Subject)
| Form SC 13D/A | |
02/28/2024
3:15 PM | Berman David M (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
3:19 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
6:33 AM | Immunocore (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/26/2024
5:46 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
3:15 PM | Immunocore (Issuer)
Jallal Bahija (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:15 PM | GOLL JOHN (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:15 PM | Berman David M (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:15 PM | Di Donato Brian (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:16 PM | Immunocore (Issuer)
St Leger Tina Amber (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:57 AM | Immunocore (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/06/2024
10:00 AM | Immunocore (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
02/01/2024
4:25 PM | BAKER BROS. ADVISORS LP (Filed by)
Immunocore (Subject)
| Form SC 13D/A | |
01/05/2024
3:17 PM | Immunocore (Issuer)
St Leger Tina Amber (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
6:19 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
4:55 PM | Immunocore (Subject)
St Leger Tina Amber (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
3:51 PM | Immunocore (Issuer)
Jallal Bahija (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:52 PM | Immunocore (Issuer)
Kaul Siddharth (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:53 PM | Immunocore (Issuer)
PEREZ ROBERT J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:54 PM | Immunocore (Issuer)
Peterson Kristine (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:55 PM | Immunocore (Issuer)
Ratcliffe Peter John (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:57 PM | Immunocore (Issuer)
St Leger Tina Amber (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:41 PM | Di Donato Brian (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Trump’s arrest is phase one (Ad) In this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America.
It’s not just about blocking Trump’s re-election…  To get all the details, go here now. |
01/02/2024
3:42 PM | Bell John Irving (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:43 PM | Berman David M (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:45 PM | Coy Travis Alan (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:47 PM | GOLL JOHN (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
5:25 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2023
4:30 PM | Immunocore (Subject)
Jallal Bahija (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
12:54 PM | Immunocore (Subject)
St Leger Tina Amber (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/30/2023
7:33 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023
8:51 AM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023
6:09 AM | Immunocore (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/06/2023
6:20 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2023
3:31 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023
1:40 PM | GENERAL ATLANTIC, L.P. (Filed by)
Immunocore (Subject)
| Form SC 13D/A | |
08/25/2023
5:10 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/17/2023
2:44 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/10/2023
7:28 AM | Immunocore (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/14/2023
3:21 PM | Immunocore (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2023
4:28 PM | Immunocore (Subject)
Jallal Bahija (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023
4:17 PM | GENERAL ATLANTIC, L.P. (Filed by)
Immunocore (Subject)
| Form SC 13D/A | |
06/05/2023
5:04 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023
8:20 AM | Immunocore (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
